SlideShare ist ein Scribd-Unternehmen logo
1 von 38
Downloaden Sie, um offline zu lesen
INTRAVENOUS ANESTHETICS
Resident: B.Ankhzaya (MNUMS )
Ketamin
• Ketamine comes as a clear colourless liquid in an ampoule.
 10mg/ml
 50mg/ml
 100mg/ml
Actions:
• Unconsiousness
• Analgesia
• Amnesia
• Intravenous (IV)- ind:1-2mg/kg main:0.5
mg/kg
• Intramuscular (IM)-ind:5-10mg/kg, main:3-
5mg/kg
• Oral (sedation)- children:15mg/kg max 500mg
It has a slower onset after an i.v. bolus (1-5 minutes).
The duration of action depends on the route of
administration (20-30 minutes for i.m. and 10-15
minutes for iv).
Route of administration
Using IV ketamine
• Premedicate with an antisialogogue (e.g.
atropine 10- 20mcg/kg)
• Anaesthesia: give 1-2mg/kg in small increments
initially to avoid episodes of apnoea. For
example 30mg boluses every 60 secs to a total of
100mg in a 70kg man. Onset is rapid (1-2 mins)
with a duration of 10 minutes. Anaesthesia can
be maintained by repeated boluses 0.5mg/kg
every 15-20 minutes or by continuous infusion
2-4 mg/kg/hr.
• (Add 500mg of ketamine to 500ml of a
crystalloid solution. Spontaneous ventilation = 1
drop/kg/min (4mg/kg/hr); Controlled ventilation
= 0.5 drop/kg min (2mg/kg/hr). The infusion is
stopped roughly 30 minutes prior to the end of
surgery.7
• Diazepam 0.1-0.2mg/kg helps to reduce
intraoperative movement and also limits
postoperative delirium.
• Analgesia - 0.5mg/kg produces rapid and
profound analgesia
Using IM ketamine
• Ideal for children and for
painful repeated procedures.
Atropine can be mixed with
ketamine for a single injection.
• Anaesthesia: 6-8mg/kg. Onset
is gradual over 5-10 minutes
and is preceded by intense
analgesia. IM titration of
maintenance doses is difficult
but 5 mg/kg every 30min is
usually adequate. An easier
technique is to prolong
anaesthesia using IV
supplements.
• Analgesia - 2-4mg/kg. Onset is
again 5-10 minutes
Pharmacokinetics of ketamine
Absorption Absorption Well absorbed orally, nasally, rectally and
intramuscularly Oral bioavailability 20%
Distribution Distribution 20-50% protein bound in plasma Volume
of distribution 3L/Kg Distribution half life is 11 mins
Recovery primarily due to redistribution from brain to
periphery
Metabolism Metabolism N-demethylation & hydroxylation of the
cyclohexylamine ring in the liver Some metabolites are
pharmacologically active
Excretion Excretion Urinary excretion of conjugated metabolites
Clearance 17ml/kg/min Elimination half life 2.5 hours
System Effect positive Effect negative
RS • preserves the laryngeal and
pharyngeal reflexes to some
degree
• ketamine is given slowly
respiration is usually well
maintained(Always have a self-
inflating bag and mask available)
• no oxygen or only limited
oxygen available
• Ketamine is an effective
bronchodilator.
• RR
• Saturation decreases when
airway obstruction
• after rapid i.v. injection the
breathing may stop for a short
while but usually restarts
within a minute.
CVS • increase in both blood
pressure and heart rate
• This is very useful in the
shocked patient but in patients
with a history of heart attack
or angina this can make their
heart disease worse.
• occasionally there can be a
large rise in blood pressure.
• patients with ischaemic heart
disease, Patients with diabetes
should have an ECG, if
available, to rule out “silent”
ischaemia (ischaemia without
chest pain)- avoided
Effect of Organ system
System Effect positive Effect negative
CNS • Ketamine provides very good
analgesia
• Co-administration of opiates or
tramadol intraoperatively can
reduce the amount of ketamine
required for maintenance of
anaesthesia and therefore reduce
the incidence and duration of
postoperative hallucinations.
• hallucinations can be reduced by
premedication with
benzodiazepines (usually
diazepam 0.15mg/kg orally 1
hour preoperatively or 0.1mg/kg)
• dissociative anaesthesia ( patient
may have their eyes open and
make reflex movements during
the operation)
• Patients can become tolerant of
ketamine. With frequent repeat
anaesthetics bigger doses are
needed, this tolerance usually
wears off over 3 days
• Co-administration (however increase the
risk of the breathing stopping during the
operation.)
• Ketamine increases the intracranial pressure
and for this reason should be avoided
wherever possible in those patients with
recent head injuries.
GIS /-/ • Ketamine increases salivation.
This can lead to airway problems
due to laryngeal spasm or
obstruction.
• It may also make the taping of
endotracheal tubes more difficult.
To reduce this salivation atropine
is usually given either as a premed
(20mcg/kg i.m.) 30 minutes
preoperatively, or at the time of
induction iv (10- 20mcg/kg).
System Effect positive Effect negative
Eyes /-/ Ketamine increases intraocular
pressure. The eyes also commonly
move continually during ketamine
anaesthesia (nystagmus). This
makes it an unsuitable anaesthetic
for eye surgery.
Skeletal Muscle /-/ Ketamine increases skeletal muscle
tone. This is most prominent after
the initial iv bolus and gradually
decreases. It is improved by
administration of benzodiazepines.
It is rarely a problem
intraoperatively.
Pain on injection No No
Patients suitable for ketamine
• Children - nausea, vomiting
and hallucinations are less
common in children
• Burns (repeated painful
procedures), trauma,
radiotherapy
• Shocked patients
• Status asthmaticus
Patients unsuitable for ketamine
• Avoid ketamine with:
Hypertension
• Ischaemic heart disease
• Pre-eclampsia
• Raised intracranial pressure
• Open eye procedures
• Acute porphyrias
Case 1 A 22 year old man has been admitted with a gunshot wound to the
abdomen. He is shocked from major internal bleeding and requires a
laparotomy. You have a very small supply of inotropes and want to try and not
use them. What will you do for induction and maintenance of anaesthesia?
• This gunshot victim is shocked and requires a laparotomy, you have limited inotropes.
• Ketamine would be an ideal anaesthetic agent in this case due to its cardiovascular effects of
raising the blood pressure and heart rate, all other anaesthetic agents tend to have a cardiac
depressant effect.
• Inductioan can be performed with iv ketamine (1-2mg/kg), atropine (10-20mcg/kg) and
diazepam (0.1mg/kg). It is still possible to perform a modified rapid sequence intubation with
ketamine, despite its slower onset time.
• There are several options for maintenance:
• 1) intermittent boluses of iv ketamine (0.5mg/kg) given according to patient’s response - pupil
size, heart rate, blood pressure, movement etc
• 2) ketamine infusion. Put 500mg of ketamine in a 500ml bag of saline or dextrose. Run this
at 1-2mls/min (1-2mg/min). Some patients may require more and others less depending on
what other drugs have been given and the type of surgery. Generally the ketamine will need to
be discontinued 20-30 minutes before the end of the operation to avoid a long wait for the
patient to wake up. This technique for laparotomy is best used with non-depolarising muscle
relaxants (avoid pancuronium as combined with ketamine may have very high blood pressure
increases). It is however possible, although more difficult, to perform the laparotomy under
ketamine alone.
Case 2 Your laparotomy patient (case 1) is back on the ward. He has severe
postoperative pain but you have been unable to get any morphine this month.
How can you manage his postoperative pain?
• ketamine for postoperative analgesia
• Ketamine is a very good analgesic and can be a solution for severe pain
when morphine is not available. Its use postoperatively is limited by the
occurrence of hallucinations, however these are less of a problem when
relatively low doses are used.
• For adult patients in severe pain a loading dose of 0.5-1 mg/kg i.m. may be
given. This can then be followed by an infusion of 60-180mcg/kg/hr (4-12
mg/hr for a 70kg adult).
.
Case 3 A 37 year old woman is recovering from 45% burns, she needs dressing changes
every two days which are very painful. She has very few sites left for i.v. access and
you don’t want to use them as she has further surgery to come. She is also very scared
of needles. How will you manage the sedation she requires for her dressing changes?
• This woman requires recurrent sedation for painful burns dressings.
IV ketamine is possible but in burns patients there are often limited
sites for cannulation and these are best saved for trips to theatre.
• IM ketamine is also an option but requires relatively large painful
i.m. injections. Instead the intravenous preparation of ketamine can
be given orally. For an adult give 500mg of ketamine + diazepam
5mg. For a child use 15mg/kg ketamine + 0.2mg/kg diazepam (you
can use the i.v. preparation but it tastes very bad and may have to be
hidden in juice). The dressing change can usually start after 20-30
minutes. Responses can sometimes be unpredictable and onset time
may be slower.
• There should always be equipment for suction and face mask
ventilation available and if possible, oxygen and a pulse oximeter.
Case 6 An 18 year old girl has been admitted with severe asthma. You have
been asked to see her as she has not improved with subcutaneous injections of
salbutamol or intravenous aminophylline. She is getting tired and her oxygen
saturation is falling. Can you do anything to help?
• ketamine for the treatment of asthma
• Ketamine is an effective bronchodilator and can be used for the patient
who is not responding to conventional bronchodilators such as salbutamol
and aminophylline.
• The doses of ketamine required are very low and problems with
hallucinations rare. A loading dose of 0.2 mg/kg iv is given initially
followed by an infusion of 0.5mg/kg/hr for 3 hours. This may be continued
if necessary. Close monitoring of the patient is required and an anaesthetist
should be available if necessary.
• Propofol is slightly soluble
in water , oil-in-water
emulsion
• pH of 6 to 8.5
• In addition to the active
component, the formulation
also contains soybean oil
(100 mg/mL), glycerol (22.5
mg/mL), egg lecithin (12
mg/mL); and disodium
edetate (0.005%)
Propofol(2,6 di-isopropylphenol)
10mg/1ml :
 200mg/20ml
 500mg/50ml
 1000mg/100ml
Acting Rapidy ,Short
Induction dose(mg/kg) 1.5-2.5mg/kg(titrated)
Hypnosis dose 100-200mcg/min
Sedation dose 25-75 mcg/min
Onset time 15-45 sec
Duration 5-10min
Pain injection ++
Pharmacokinetics of propofol
Absorption Following an IV bolus
Distribution there is rapid equilibration between the plasma and the
highly perfused tissue of the brain as described earlier.
Plasma levels decline rapidly as a result of
redistribution,
Metabolism followed by a more prolonged period of hepatic
metabolism and renal clearance. The initial
redistribution half-life is between 2 and 4 minutes
Excretion Excretion Urinary excretion of conjugated metabolites
Clearance 20-30ml/kg/min Elimination half life 14-23
hours
System Effect positive Effect negative
CVS /-/ • This is mainly due to systemic
vasodilatation
Blood pressure heart rate or
slighty
RR /-/ • Act on the respiratory centre to
cause respiratory depression.
This effect is the most profound
with propofol and a period of
apnoea is usually seen. (25-35%)
• Propofol also markedly reduces
airway and pharyngeal reflexes,
making it the ideal drug to use
with the laryngeal mask
CNS • Anticonvulsant in normal
doses.
• Most minimum vomitin g and
naussea
CMRO, CBF, ICP reduced
Effect of Organ system
• Propofol infusion syndrome (PRIS) is defined as acute bradycardia
progressing to asystole combined with lipemic plasma, fatty liver
enlargement, metabolic acidosis with negative base excess >10 mmol . l -1,
rhabdomyolysis or myoglobinuria associated with propofol infusion
Etiology & Risk factors
• airway infection,
• severe head injury,
• high-dose long-term propofol sedation
for more than 48 h at more than 5 mg.
kg-1. h-1, increased catecholamine and
glucocorticoid serum levels
• low energy supply
• poor oxygen delivery,
• sepsis
• lipemia,
• likely due to a failure of hepatic lipid
regulation, possibly related to poor
oxygenation or low glucose plasma
levels
Bradycardia has to be combined with
• lipemic plasma,
• fatty liver enlargement,
• metabolic acidosis with negative
base excess >10 mmol . l-1,
• rhabdomyolysis or myoglobinuria
Symptoms and signs are lactacidosis,
arrhythmia, hypotension, renal, cardiac and
circulatory failure, oliguria, rhabdomyolysis,
elevated serum creatine kinase, serum urea
and serum potassium, lipemic plasma, liver
enlargement, ketonuria, increased liver
enzymes and green or red coloured urine.
Propofol infusion syndrom(PRIS)
Death was more likely if the patients were younger than 19 yearsof age, males or
received a vasopressor. Other identified risk factors for death were cardiac
manifestations, metabolic acidosis, renal failure, hypotension, rhabdomyolysis or
dyslipidemia
Pathophysiology
• PRIS are cytolysis of skeletal and cardiac
muscle cells
• Muscle biopsies and fat metabolism
analyses of patients with PRIS resemble
these found in mitochondrial cytopathias
and acquired acyl-carnitine metabolism
deficiencies by inhibition of beta
oxidation.
• PRIS may be aggravated by concomitant
diseases like cardiomyopathy.
• Low carbohydrate supply is a risk factor
for PRIS, because energy demand is
satisfied by lipolysis if carbohydrate
supply is low. Children are more prone to
the development of PRIS due to ow
glycogen storage and high dependence on
fat metabolism.43 Fat overload associated
with propofol infusion may also contribute
to increased plasma fatty acids
Therapy
• Propofol infusion must be stopped
immediately.
• Hemodynamic stabilization has to
be achieved by routine intensive
care procedures. Unfortunately,
bradycardia is often resistant to
catecholamines and external
pacing.
• Carbohydrate substitution is
recommended at 6-8 mg.kg.min
• Hemodialysis or hemofiltration is
recommended for elimination of
propofol and its potentially toxic
metabolites
• Sodium thiopentone (also known
as thiopental or pentothal) is
prepared by dissolving a
yellowish powder in sterile water
to provide a 2.5% solution (ie
25mg/ml).
• In this concentration 20mls of
solution will contain 500mg.
• Ph=10,8 alkaline
• Thiopentone can be used as the
sole anaesthetic agent for very
brief procedures.
Thiopentone (thiopentanyl sodium)
Acting Rapidly ,smooth barbiturates
Onset (arm-brain time ) 15—30 sec
Duration 5-10 min
Induction dose 3-7mg/kg
Pain injection 0/+ (Pain would suggest extravascular or intraarterial
injection)
Recovery time Rapidly
low incidence of nausea and vomiting.
• Following induction anaesthesia is usually maintained by breathing an anaesthetic
vapour such as halothane.
• Titrate the dose against effect; the loss of the eyelash reflex is a good guide to loss of
consciousness.
System Effect positive Effect negative
CNS • Thiopentone can also be used in
Intensive Care patients with head
injuries to control surges in
intracranial pressure.
• it posesses potent anticonvulsant
activity it may be given to treat
epileptic seizures
• CMRO, CBF
GIS and US • It does not have any direct toxic
effects on the liver or kidney, but
patients with liver or kidney
disease may require a lower dose
range than 3 to 7 mg/kg.
/-/
CVS • it increases heart rate, coronary
blood flow, and the oxygen demand
of the heart.
• Thiopentone directly depresses the
contractile force of the heart
• can cause hypotension in patients
who are hypovolaemic (eg
following haemorrhage).
• also causes a decrease in venous
tone, causing pooling of blood in
the peripheral veins;
Analgesic and muscle relaxant Thiopentone has no analgesic
properties, in fact in low doses it tends
to heighten sensitivity to pain. It has
poor muscle relaxant properties.
/-/
Effect of Organ system
• 1. Acute intermittent porphyria
• 2. Barbiturate allergy
• 3. Patients with a low circulating blood volume, such as after
haemorrhage, are prone to severe hypotension with thiopentone.
• 4. Patients with cardiac disease (particularly those with stenotic
heart valve lesions) are at risk from the cardiovascular depressant
effects of thiopentone. The drug must be carefully titrated against
effect.
• 5. Patients with partial airway obstruction should not be given an
intravenous anaesthetic agent in case total airway obstruction
develops.
• 6. In severe asthma it is thought that thiopentone may occasionally
cause bronchospasm.
Contraindications:
Thiopentone is metabolised in the liver; less than 1% of the drug appears in the
urine unchanged.
• Midazolam is a water
soluble benzodiazepine. It
comes as a clear solution.
 1mg/ml
 5mg/ml
• Actions: unconsiousness,
sedation , anxiolytic,
anticonvulant , amnesia
Benzodiazepines(Midazolam)
Acting
Sedation dose 0.05-0.1mg.kg(IV). Short duration
Oral dose (children) 0.5mg.kg Premedication 30min
preoperative
Induction dose 0.3mg.kg(0.2-0.4mg.kg
IV)
Onset time 30-90sec
Duration time 10-30min
Pain injection /-/
It undergoes hepatic metabolism (+glucorinide or oxidation)and renal elimination. In
the elderly, the lower hepatic blood flow and metabolic activity result in a significantly
prolonged half life.
Liver clearance rate : midazolam >lorazepam >diazepam
System Effect positive Effect negative
CvS /-/ Mild depressant*
RS /-/ Mild depressant *
CNS Anticonvulsant
,antiepileptic
CMRO2 and CBF
*-dose dependant (monitoring is important duration sedation)
When used as a sole induction drug, midazolam causes apnoea in up to 70% of
patients
The effects of midazolam can be reversed with flumazenil, a competitive
benzodiazepine antagonist. This should be given by intravenous injection in 100mcg
increments and should act with in 2 minutes. Flumazenil must be used cautiously, as it
can cause agitation and seizures
Effect of Organ system
• Diazepam is exclusively lipid
soluble, water insoluble due to its
carbon-containing ring structure.
• This property makes it a rapidly
absorbed by the oral route but also
means that it must be formulated
as a lipid emulsion (diazemuls)
for intravenous use
 5mg/1ml
Diazepam
Diazepam
Induction dose 0.3-0.6mg.kg
Dose in children 0.2-0.3mg.kg
Onset time 45-60sec
Duration time 15-30min
Pain on injectin +++
Diazepam causes cardiorespiratory compromise, particularly when co-administered
with opioids.
• Etomidate is an imidazole ester.
• It is usually presented as a lipid
emulsion or as a clear solution
containing propylene glycol at a
concentration of 2mg.ml
 2mg/ml
Etomidate
Induction dose 0.2-0.3 mg.kg
Sedation dose 0.03-0.05mg.kg
Onset time 15-45sec
Duration time 3-12min
Pain on injectin +++
Recovery rapid (accompanied by nausea and
vomiting)
It is rapidly metabolized by hepatic and plasma esterases to yield inactive
metabolites. Excretion is predominantly urinary and the elimination half life varies
from 1 – 5 hours.
System Effect positive Effect negative
CVS • widely used to induce
anaesthesia in the shocked,
elderly or cardiovascularly
compromised patient
• Hemodynamic suitable
• Least cardiovascular
depression of the IV
anaesthetic drugs, with only a
small reduction in the cardiac
output and blood pressure.
• Deppressant trombocytes ,
prolonged bleeding time
RS /-/ • causes transient apnoea,
though less so than other
drugs, and can cause
cough or hiccups
Post operative nausea and vomiting is common after etomidate administration
MOST MINIMUM DEPRESSANT !!!!!
Effect of Organ system
• Etomidate inhibits 11-β-hydroxylase, an enzyme important in adrenal
steroid production.
• A single induction dose blocks the normal stress-induced increase in
adrenal cortisol production for 4-8 hours, and up to 24 hours in elderly and
debilitated patients.
• Continuous infusion of etomidate for sedation in critically ill patients has
been shown to increase mortality.
• Although no increase in mortality has been identified following a single
dose during induction of anesthesia, the use of etomidate has declined in
recent years due to a perceived potential morbidity
Etomidate
Weblinks:
1. file:///H:/%C2%A0/Books%20of%20Anesthesiology/Pharmacology%20and%20Ph
ysiology%20for%20Anaesthesia.pdf
2. file:///H:/%C2%A0/Books%20of%20Anesthesiology/Barash's%20Handbook%20of
%20Clinical%20Anesthesia%207th%20Edition.pdf
3. http://www.e-safe-
anaesthesia.org/e_library/03/Ketamine_in_anaesthetic_practice_TOTW_027_2006.
pdf
4. http://www.e-safe-
anaesthesia.org/e_library/03/Induction_drugs_used_in_anaesthesia_Update_2008.p
df
5. http://www.e-safe-anaesthesia.org/e_library/03/Thiopentone_Update_1993.pdf
6. https://www.minervamedica.it/en/getfreepdf/7Bgc25XMfY%252FxrQmpROZRCio
IEuJjmBgj1OVQvpXO4zG%252B5tbWLZvXw0Ot70ybHmn6VRMbuu9yOvnNu
%252FBxEqzYBg%253D%253D/R02Y2009N05A0339.pdf
Intravenous Agents

Weitere ähnliche Inhalte

Was ist angesagt?

Intravenous Anaesthetics (Intro)
Intravenous Anaesthetics (Intro)Intravenous Anaesthetics (Intro)
Intravenous Anaesthetics (Intro)Andrew Ferguson
 
Ketamine education 2017 (3)
Ketamine education 2017 (3)Ketamine education 2017 (3)
Ketamine education 2017 (3)tracyw1976
 
Sympathomimetic agents/ Adrenergic drug
Sympathomimetic agents/ Adrenergic drugSympathomimetic agents/ Adrenergic drug
Sympathomimetic agents/ Adrenergic drugSKarthigaSVCP
 
Sympathomimetic System- Pharmacology
Sympathomimetic System- PharmacologySympathomimetic System- Pharmacology
Sympathomimetic System- PharmacologyAdarshPatel73
 
Skeletal muscle relaxant
Skeletal muscle relaxantSkeletal muscle relaxant
Skeletal muscle relaxantSabaShaikh76
 
Anaesthetics
AnaestheticsAnaesthetics
AnaestheticsEneutron
 
Intravenous inductional agents ( anesthesiology & critical care)
Intravenous inductional agents ( anesthesiology & critical care)Intravenous inductional agents ( anesthesiology & critical care)
Intravenous inductional agents ( anesthesiology & critical care)Shiv Sunder
 
Sympathomimetics
SympathomimeticsSympathomimetics
SympathomimeticsKalyaniR5
 
Intravenous anaesthetic agents
Intravenous anaesthetic agentsIntravenous anaesthetic agents
Intravenous anaesthetic agentsPriyanka Mahanta
 
Parasympathomimetic agents
Parasympathomimetic agentsParasympathomimetic agents
Parasympathomimetic agentsKirti Vadi
 
Ketamine & its role in palliative care
Ketamine & its role in palliative careKetamine & its role in palliative care
Ketamine & its role in palliative careAnuja Bidkar
 

Was ist angesagt? (20)

Intravenous anaesthetic agents
Intravenous anaesthetic agentsIntravenous anaesthetic agents
Intravenous anaesthetic agents
 
Etomidate ketamine
Etomidate ketamineEtomidate ketamine
Etomidate ketamine
 
Ketamine poonam
Ketamine poonamKetamine poonam
Ketamine poonam
 
Etomidate a to z
Etomidate a to zEtomidate a to z
Etomidate a to z
 
Midazolam in er 1
Midazolam in er 1Midazolam in er 1
Midazolam in er 1
 
Intravenous Anaesthetics (Intro)
Intravenous Anaesthetics (Intro)Intravenous Anaesthetics (Intro)
Intravenous Anaesthetics (Intro)
 
Ketamine education 2017 (3)
Ketamine education 2017 (3)Ketamine education 2017 (3)
Ketamine education 2017 (3)
 
Sympathomimetic agents/ Adrenergic drug
Sympathomimetic agents/ Adrenergic drugSympathomimetic agents/ Adrenergic drug
Sympathomimetic agents/ Adrenergic drug
 
Thiopentone upendra
Thiopentone upendraThiopentone upendra
Thiopentone upendra
 
Sympathomimetic System- Pharmacology
Sympathomimetic System- PharmacologySympathomimetic System- Pharmacology
Sympathomimetic System- Pharmacology
 
Skeletal muscle relaxant
Skeletal muscle relaxantSkeletal muscle relaxant
Skeletal muscle relaxant
 
Anaesthetics
AnaestheticsAnaesthetics
Anaesthetics
 
Intravenous inductional agents ( anesthesiology & critical care)
Intravenous inductional agents ( anesthesiology & critical care)Intravenous inductional agents ( anesthesiology & critical care)
Intravenous inductional agents ( anesthesiology & critical care)
 
Sympathomimetics
SympathomimeticsSympathomimetics
Sympathomimetics
 
Intravenous anaesthetic agents
Intravenous anaesthetic agentsIntravenous anaesthetic agents
Intravenous anaesthetic agents
 
Muscle releaxent toxicity
Muscle releaxent toxicityMuscle releaxent toxicity
Muscle releaxent toxicity
 
Parasympathomimetic agents
Parasympathomimetic agentsParasympathomimetic agents
Parasympathomimetic agents
 
Sympathomimetic drugs
Sympathomimetic drugsSympathomimetic drugs
Sympathomimetic drugs
 
Anesthesia 5th year, 7th & 8th lectures (Dr. Aamir)
Anesthesia 5th year, 7th & 8th lectures (Dr. Aamir)Anesthesia 5th year, 7th & 8th lectures (Dr. Aamir)
Anesthesia 5th year, 7th & 8th lectures (Dr. Aamir)
 
Ketamine & its role in palliative care
Ketamine & its role in palliative careKetamine & its role in palliative care
Ketamine & its role in palliative care
 

Ähnlich wie Intravenous Agents

ketamine-ريرتي150821121016-lva1-app6891.pptx
ketamine-ريرتي150821121016-lva1-app6891.pptxketamine-ريرتي150821121016-lva1-app6891.pptx
ketamine-ريرتي150821121016-lva1-app6891.pptxshalloshibani
 
Ketamine Injection USP Taj Pharma SmPC
Ketamine Injection USP Taj Pharma SmPCKetamine Injection USP Taj Pharma SmPC
Ketamine Injection USP Taj Pharma SmPCTajPharmaQC
 
Induction Agents - Propofol, Sodium Thiopental, Ketamine,
Induction Agents - Propofol, Sodium Thiopental, Ketamine, Induction Agents - Propofol, Sodium Thiopental, Ketamine,
Induction Agents - Propofol, Sodium Thiopental, Ketamine, Mr.Harshad Khade
 
Acute asthma exacerbations in children
Acute asthma exacerbations in childrenAcute asthma exacerbations in children
Acute asthma exacerbations in childrenDrOdongRichardJustin
 
Skeleton plan on drugs used in obstetrics
Skeleton plan on drugs used in obstetricsSkeleton plan on drugs used in obstetrics
Skeleton plan on drugs used in obstetricschristenashantaram
 
2016 10 06 hartford hospital 2016 state protocol update
2016 10 06 hartford hospital 2016 state protocol update2016 10 06 hartford hospital 2016 state protocol update
2016 10 06 hartford hospital 2016 state protocol updatedinterlandi
 
KetamineFINALdraft
KetamineFINALdraftKetamineFINALdraft
KetamineFINALdraftIrena Surina
 
TDM Gentamicin .pdf
TDM Gentamicin .pdfTDM Gentamicin .pdf
TDM Gentamicin .pdfUVAS
 
Post-Intubation Management
Post-Intubation ManagementPost-Intubation Management
Post-Intubation ManagementSCGH ED CME
 
Tocolytic Drugs.pptx
Tocolytic Drugs.pptxTocolytic Drugs.pptx
Tocolytic Drugs.pptxAsikin Sakri
 
Decontamination, specific antidotes
Decontamination, specific antidotesDecontamination, specific antidotes
Decontamination, specific antidotesDomina Petric
 
OXYTOCIN.pptx
OXYTOCIN.pptxOXYTOCIN.pptx
OXYTOCIN.pptxannesphoo
 
Anesthetic medications
Anesthetic medicationsAnesthetic medications
Anesthetic medicationsAyub Abdi
 
DRUGS AND DEFIBRILATION.ppt
DRUGS AND DEFIBRILATION.pptDRUGS AND DEFIBRILATION.ppt
DRUGS AND DEFIBRILATION.pptAgusHaryanto56
 
Medications in pediatrics
Medications in pediatricsMedications in pediatrics
Medications in pediatricsPratik Kumar
 
Medications in pediatrics
Medications in pediatricsMedications in pediatrics
Medications in pediatricsPratik Kumar
 
campbell walsh 12th edition.pptx
campbell walsh 12th edition.pptxcampbell walsh 12th edition.pptx
campbell walsh 12th edition.pptxDrIbrahimSadoon
 

Ähnlich wie Intravenous Agents (20)

ketamine-ريرتي150821121016-lva1-app6891.pptx
ketamine-ريرتي150821121016-lva1-app6891.pptxketamine-ريرتي150821121016-lva1-app6891.pptx
ketamine-ريرتي150821121016-lva1-app6891.pptx
 
Ketamine Injection USP Taj Pharma SmPC
Ketamine Injection USP Taj Pharma SmPCKetamine Injection USP Taj Pharma SmPC
Ketamine Injection USP Taj Pharma SmPC
 
Ketamine
KetamineKetamine
Ketamine
 
Induction Agents - Propofol, Sodium Thiopental, Ketamine,
Induction Agents - Propofol, Sodium Thiopental, Ketamine, Induction Agents - Propofol, Sodium Thiopental, Ketamine,
Induction Agents - Propofol, Sodium Thiopental, Ketamine,
 
Acute asthma exacerbations in children
Acute asthma exacerbations in childrenAcute asthma exacerbations in children
Acute asthma exacerbations in children
 
Skeleton plan on drugs used in obstetrics
Skeleton plan on drugs used in obstetricsSkeleton plan on drugs used in obstetrics
Skeleton plan on drugs used in obstetrics
 
2016 10 06 hartford hospital 2016 state protocol update
2016 10 06 hartford hospital 2016 state protocol update2016 10 06 hartford hospital 2016 state protocol update
2016 10 06 hartford hospital 2016 state protocol update
 
Local anaesthetics by aga umar
Local anaesthetics by aga umarLocal anaesthetics by aga umar
Local anaesthetics by aga umar
 
KetamineFINALdraft
KetamineFINALdraftKetamineFINALdraft
KetamineFINALdraft
 
TDM Gentamicin .pdf
TDM Gentamicin .pdfTDM Gentamicin .pdf
TDM Gentamicin .pdf
 
Post-Intubation Management
Post-Intubation ManagementPost-Intubation Management
Post-Intubation Management
 
Antiplatelets
Antiplatelets  Antiplatelets
Antiplatelets
 
Tocolytic Drugs.pptx
Tocolytic Drugs.pptxTocolytic Drugs.pptx
Tocolytic Drugs.pptx
 
Decontamination, specific antidotes
Decontamination, specific antidotesDecontamination, specific antidotes
Decontamination, specific antidotes
 
OXYTOCIN.pptx
OXYTOCIN.pptxOXYTOCIN.pptx
OXYTOCIN.pptx
 
Anesthetic medications
Anesthetic medicationsAnesthetic medications
Anesthetic medications
 
DRUGS AND DEFIBRILATION.ppt
DRUGS AND DEFIBRILATION.pptDRUGS AND DEFIBRILATION.ppt
DRUGS AND DEFIBRILATION.ppt
 
Medications in pediatrics
Medications in pediatricsMedications in pediatrics
Medications in pediatrics
 
Medications in pediatrics
Medications in pediatricsMedications in pediatrics
Medications in pediatrics
 
campbell walsh 12th edition.pptx
campbell walsh 12th edition.pptxcampbell walsh 12th edition.pptx
campbell walsh 12th edition.pptx
 

Mehr von Ankhzaya Zaya

Local anesthetics and additives
Local anesthetics and additives Local anesthetics and additives
Local anesthetics and additives Ankhzaya Zaya
 
Neuromuscular blockade & Reversal agents & Monitoring
Neuromuscular blockade & Reversal agents & Monitoring  Neuromuscular blockade & Reversal agents & Monitoring
Neuromuscular blockade & Reversal agents & Monitoring Ankhzaya Zaya
 
Барьцалдаат спондилит
Барьцалдаат спондилитБарьцалдаат спондилит
Барьцалдаат спондилитAnkhzaya Zaya
 
эрүүл бие зөв хоололт
эрүүл бие зөв хоололтэрүүл бие зөв хоололт
эрүүл бие зөв хоололтAnkhzaya Zaya
 

Mehr von Ankhzaya Zaya (9)

PLS
PLSPLS
PLS
 
Airway management
Airway management Airway management
Airway management
 
Local anesthetics and additives
Local anesthetics and additives Local anesthetics and additives
Local anesthetics and additives
 
Neuromuscular blockade & Reversal agents & Monitoring
Neuromuscular blockade & Reversal agents & Monitoring  Neuromuscular blockade & Reversal agents & Monitoring
Neuromuscular blockade & Reversal agents & Monitoring
 
Барьцалдаат спондилит
Барьцалдаат спондилитБарьцалдаат спондилит
Барьцалдаат спондилит
 
Блефарит
БлефаритБлефарит
Блефарит
 
PET
PETPET
PET
 
эрүүл бие зөв хоололт
эрүүл бие зөв хоололтэрүүл бие зөв хоололт
эрүүл бие зөв хоололт
 
Ondgovchnii havdar
Ondgovchnii havdarOndgovchnii havdar
Ondgovchnii havdar
 

Kürzlich hochgeladen

Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medicationMohamadAlhes
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinethanaram patel
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..AneriPatwari
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingSakthi Kathiravan
 
Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyHasnat Tariq
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMADivya Kanojiya
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxEyobAlemu11
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 

Kürzlich hochgeladen (20)

Valproic Acid. (VPA). Antiseizure medication
Valproic Acid.  (VPA). Antiseizure medicationValproic Acid.  (VPA). Antiseizure medication
Valproic Acid. (VPA). Antiseizure medication
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
medico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicinemedico legal aspects of wound - forensic medicine
medico legal aspects of wound - forensic medicine
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..PHYSIOTHERAPY IN HEART TRANSPLANTATION..
PHYSIOTHERAPY IN HEART TRANSPLANTATION..
 
LESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursingLESSON PLAN ON fever.pdf child health nursing
LESSON PLAN ON fever.pdf child health nursing
 
Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technology
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMAANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
ANTI-DIABETICS DRUGS - PTEROCARPUS AND GYMNEMA
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
systemic bacteriology (7)............pptx
systemic bacteriology (7)............pptxsystemic bacteriology (7)............pptx
systemic bacteriology (7)............pptx
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 

Intravenous Agents

  • 3. • Ketamine comes as a clear colourless liquid in an ampoule.  10mg/ml  50mg/ml  100mg/ml Actions: • Unconsiousness • Analgesia • Amnesia
  • 4. • Intravenous (IV)- ind:1-2mg/kg main:0.5 mg/kg • Intramuscular (IM)-ind:5-10mg/kg, main:3- 5mg/kg • Oral (sedation)- children:15mg/kg max 500mg It has a slower onset after an i.v. bolus (1-5 minutes). The duration of action depends on the route of administration (20-30 minutes for i.m. and 10-15 minutes for iv). Route of administration
  • 5. Using IV ketamine • Premedicate with an antisialogogue (e.g. atropine 10- 20mcg/kg) • Anaesthesia: give 1-2mg/kg in small increments initially to avoid episodes of apnoea. For example 30mg boluses every 60 secs to a total of 100mg in a 70kg man. Onset is rapid (1-2 mins) with a duration of 10 minutes. Anaesthesia can be maintained by repeated boluses 0.5mg/kg every 15-20 minutes or by continuous infusion 2-4 mg/kg/hr. • (Add 500mg of ketamine to 500ml of a crystalloid solution. Spontaneous ventilation = 1 drop/kg/min (4mg/kg/hr); Controlled ventilation = 0.5 drop/kg min (2mg/kg/hr). The infusion is stopped roughly 30 minutes prior to the end of surgery.7 • Diazepam 0.1-0.2mg/kg helps to reduce intraoperative movement and also limits postoperative delirium. • Analgesia - 0.5mg/kg produces rapid and profound analgesia Using IM ketamine • Ideal for children and for painful repeated procedures. Atropine can be mixed with ketamine for a single injection. • Anaesthesia: 6-8mg/kg. Onset is gradual over 5-10 minutes and is preceded by intense analgesia. IM titration of maintenance doses is difficult but 5 mg/kg every 30min is usually adequate. An easier technique is to prolong anaesthesia using IV supplements. • Analgesia - 2-4mg/kg. Onset is again 5-10 minutes
  • 6. Pharmacokinetics of ketamine Absorption Absorption Well absorbed orally, nasally, rectally and intramuscularly Oral bioavailability 20% Distribution Distribution 20-50% protein bound in plasma Volume of distribution 3L/Kg Distribution half life is 11 mins Recovery primarily due to redistribution from brain to periphery Metabolism Metabolism N-demethylation & hydroxylation of the cyclohexylamine ring in the liver Some metabolites are pharmacologically active Excretion Excretion Urinary excretion of conjugated metabolites Clearance 17ml/kg/min Elimination half life 2.5 hours
  • 7. System Effect positive Effect negative RS • preserves the laryngeal and pharyngeal reflexes to some degree • ketamine is given slowly respiration is usually well maintained(Always have a self- inflating bag and mask available) • no oxygen or only limited oxygen available • Ketamine is an effective bronchodilator. • RR • Saturation decreases when airway obstruction • after rapid i.v. injection the breathing may stop for a short while but usually restarts within a minute. CVS • increase in both blood pressure and heart rate • This is very useful in the shocked patient but in patients with a history of heart attack or angina this can make their heart disease worse. • occasionally there can be a large rise in blood pressure. • patients with ischaemic heart disease, Patients with diabetes should have an ECG, if available, to rule out “silent” ischaemia (ischaemia without chest pain)- avoided Effect of Organ system
  • 8. System Effect positive Effect negative CNS • Ketamine provides very good analgesia • Co-administration of opiates or tramadol intraoperatively can reduce the amount of ketamine required for maintenance of anaesthesia and therefore reduce the incidence and duration of postoperative hallucinations. • hallucinations can be reduced by premedication with benzodiazepines (usually diazepam 0.15mg/kg orally 1 hour preoperatively or 0.1mg/kg) • dissociative anaesthesia ( patient may have their eyes open and make reflex movements during the operation) • Patients can become tolerant of ketamine. With frequent repeat anaesthetics bigger doses are needed, this tolerance usually wears off over 3 days • Co-administration (however increase the risk of the breathing stopping during the operation.) • Ketamine increases the intracranial pressure and for this reason should be avoided wherever possible in those patients with recent head injuries. GIS /-/ • Ketamine increases salivation. This can lead to airway problems due to laryngeal spasm or obstruction. • It may also make the taping of endotracheal tubes more difficult. To reduce this salivation atropine is usually given either as a premed (20mcg/kg i.m.) 30 minutes preoperatively, or at the time of induction iv (10- 20mcg/kg).
  • 9. System Effect positive Effect negative Eyes /-/ Ketamine increases intraocular pressure. The eyes also commonly move continually during ketamine anaesthesia (nystagmus). This makes it an unsuitable anaesthetic for eye surgery. Skeletal Muscle /-/ Ketamine increases skeletal muscle tone. This is most prominent after the initial iv bolus and gradually decreases. It is improved by administration of benzodiazepines. It is rarely a problem intraoperatively. Pain on injection No No
  • 10. Patients suitable for ketamine • Children - nausea, vomiting and hallucinations are less common in children • Burns (repeated painful procedures), trauma, radiotherapy • Shocked patients • Status asthmaticus Patients unsuitable for ketamine • Avoid ketamine with: Hypertension • Ischaemic heart disease • Pre-eclampsia • Raised intracranial pressure • Open eye procedures • Acute porphyrias
  • 11. Case 1 A 22 year old man has been admitted with a gunshot wound to the abdomen. He is shocked from major internal bleeding and requires a laparotomy. You have a very small supply of inotropes and want to try and not use them. What will you do for induction and maintenance of anaesthesia? • This gunshot victim is shocked and requires a laparotomy, you have limited inotropes. • Ketamine would be an ideal anaesthetic agent in this case due to its cardiovascular effects of raising the blood pressure and heart rate, all other anaesthetic agents tend to have a cardiac depressant effect. • Inductioan can be performed with iv ketamine (1-2mg/kg), atropine (10-20mcg/kg) and diazepam (0.1mg/kg). It is still possible to perform a modified rapid sequence intubation with ketamine, despite its slower onset time. • There are several options for maintenance: • 1) intermittent boluses of iv ketamine (0.5mg/kg) given according to patient’s response - pupil size, heart rate, blood pressure, movement etc • 2) ketamine infusion. Put 500mg of ketamine in a 500ml bag of saline or dextrose. Run this at 1-2mls/min (1-2mg/min). Some patients may require more and others less depending on what other drugs have been given and the type of surgery. Generally the ketamine will need to be discontinued 20-30 minutes before the end of the operation to avoid a long wait for the patient to wake up. This technique for laparotomy is best used with non-depolarising muscle relaxants (avoid pancuronium as combined with ketamine may have very high blood pressure increases). It is however possible, although more difficult, to perform the laparotomy under ketamine alone.
  • 12. Case 2 Your laparotomy patient (case 1) is back on the ward. He has severe postoperative pain but you have been unable to get any morphine this month. How can you manage his postoperative pain? • ketamine for postoperative analgesia • Ketamine is a very good analgesic and can be a solution for severe pain when morphine is not available. Its use postoperatively is limited by the occurrence of hallucinations, however these are less of a problem when relatively low doses are used. • For adult patients in severe pain a loading dose of 0.5-1 mg/kg i.m. may be given. This can then be followed by an infusion of 60-180mcg/kg/hr (4-12 mg/hr for a 70kg adult). .
  • 13. Case 3 A 37 year old woman is recovering from 45% burns, she needs dressing changes every two days which are very painful. She has very few sites left for i.v. access and you don’t want to use them as she has further surgery to come. She is also very scared of needles. How will you manage the sedation she requires for her dressing changes? • This woman requires recurrent sedation for painful burns dressings. IV ketamine is possible but in burns patients there are often limited sites for cannulation and these are best saved for trips to theatre. • IM ketamine is also an option but requires relatively large painful i.m. injections. Instead the intravenous preparation of ketamine can be given orally. For an adult give 500mg of ketamine + diazepam 5mg. For a child use 15mg/kg ketamine + 0.2mg/kg diazepam (you can use the i.v. preparation but it tastes very bad and may have to be hidden in juice). The dressing change can usually start after 20-30 minutes. Responses can sometimes be unpredictable and onset time may be slower. • There should always be equipment for suction and face mask ventilation available and if possible, oxygen and a pulse oximeter.
  • 14. Case 6 An 18 year old girl has been admitted with severe asthma. You have been asked to see her as she has not improved with subcutaneous injections of salbutamol or intravenous aminophylline. She is getting tired and her oxygen saturation is falling. Can you do anything to help? • ketamine for the treatment of asthma • Ketamine is an effective bronchodilator and can be used for the patient who is not responding to conventional bronchodilators such as salbutamol and aminophylline. • The doses of ketamine required are very low and problems with hallucinations rare. A loading dose of 0.2 mg/kg iv is given initially followed by an infusion of 0.5mg/kg/hr for 3 hours. This may be continued if necessary. Close monitoring of the patient is required and an anaesthetist should be available if necessary.
  • 15. • Propofol is slightly soluble in water , oil-in-water emulsion • pH of 6 to 8.5 • In addition to the active component, the formulation also contains soybean oil (100 mg/mL), glycerol (22.5 mg/mL), egg lecithin (12 mg/mL); and disodium edetate (0.005%) Propofol(2,6 di-isopropylphenol)
  • 16. 10mg/1ml :  200mg/20ml  500mg/50ml  1000mg/100ml
  • 17. Acting Rapidy ,Short Induction dose(mg/kg) 1.5-2.5mg/kg(titrated) Hypnosis dose 100-200mcg/min Sedation dose 25-75 mcg/min Onset time 15-45 sec Duration 5-10min Pain injection ++
  • 18. Pharmacokinetics of propofol Absorption Following an IV bolus Distribution there is rapid equilibration between the plasma and the highly perfused tissue of the brain as described earlier. Plasma levels decline rapidly as a result of redistribution, Metabolism followed by a more prolonged period of hepatic metabolism and renal clearance. The initial redistribution half-life is between 2 and 4 minutes Excretion Excretion Urinary excretion of conjugated metabolites Clearance 20-30ml/kg/min Elimination half life 14-23 hours
  • 19. System Effect positive Effect negative CVS /-/ • This is mainly due to systemic vasodilatation Blood pressure heart rate or slighty RR /-/ • Act on the respiratory centre to cause respiratory depression. This effect is the most profound with propofol and a period of apnoea is usually seen. (25-35%) • Propofol also markedly reduces airway and pharyngeal reflexes, making it the ideal drug to use with the laryngeal mask CNS • Anticonvulsant in normal doses. • Most minimum vomitin g and naussea CMRO, CBF, ICP reduced Effect of Organ system
  • 20. • Propofol infusion syndrome (PRIS) is defined as acute bradycardia progressing to asystole combined with lipemic plasma, fatty liver enlargement, metabolic acidosis with negative base excess >10 mmol . l -1, rhabdomyolysis or myoglobinuria associated with propofol infusion Etiology & Risk factors • airway infection, • severe head injury, • high-dose long-term propofol sedation for more than 48 h at more than 5 mg. kg-1. h-1, increased catecholamine and glucocorticoid serum levels • low energy supply • poor oxygen delivery, • sepsis • lipemia, • likely due to a failure of hepatic lipid regulation, possibly related to poor oxygenation or low glucose plasma levels Bradycardia has to be combined with • lipemic plasma, • fatty liver enlargement, • metabolic acidosis with negative base excess >10 mmol . l-1, • rhabdomyolysis or myoglobinuria Symptoms and signs are lactacidosis, arrhythmia, hypotension, renal, cardiac and circulatory failure, oliguria, rhabdomyolysis, elevated serum creatine kinase, serum urea and serum potassium, lipemic plasma, liver enlargement, ketonuria, increased liver enzymes and green or red coloured urine. Propofol infusion syndrom(PRIS)
  • 21. Death was more likely if the patients were younger than 19 yearsof age, males or received a vasopressor. Other identified risk factors for death were cardiac manifestations, metabolic acidosis, renal failure, hypotension, rhabdomyolysis or dyslipidemia Pathophysiology • PRIS are cytolysis of skeletal and cardiac muscle cells • Muscle biopsies and fat metabolism analyses of patients with PRIS resemble these found in mitochondrial cytopathias and acquired acyl-carnitine metabolism deficiencies by inhibition of beta oxidation. • PRIS may be aggravated by concomitant diseases like cardiomyopathy. • Low carbohydrate supply is a risk factor for PRIS, because energy demand is satisfied by lipolysis if carbohydrate supply is low. Children are more prone to the development of PRIS due to ow glycogen storage and high dependence on fat metabolism.43 Fat overload associated with propofol infusion may also contribute to increased plasma fatty acids Therapy • Propofol infusion must be stopped immediately. • Hemodynamic stabilization has to be achieved by routine intensive care procedures. Unfortunately, bradycardia is often resistant to catecholamines and external pacing. • Carbohydrate substitution is recommended at 6-8 mg.kg.min • Hemodialysis or hemofiltration is recommended for elimination of propofol and its potentially toxic metabolites
  • 22. • Sodium thiopentone (also known as thiopental or pentothal) is prepared by dissolving a yellowish powder in sterile water to provide a 2.5% solution (ie 25mg/ml). • In this concentration 20mls of solution will contain 500mg. • Ph=10,8 alkaline • Thiopentone can be used as the sole anaesthetic agent for very brief procedures. Thiopentone (thiopentanyl sodium)
  • 23. Acting Rapidly ,smooth barbiturates Onset (arm-brain time ) 15—30 sec Duration 5-10 min Induction dose 3-7mg/kg Pain injection 0/+ (Pain would suggest extravascular or intraarterial injection) Recovery time Rapidly low incidence of nausea and vomiting. • Following induction anaesthesia is usually maintained by breathing an anaesthetic vapour such as halothane. • Titrate the dose against effect; the loss of the eyelash reflex is a good guide to loss of consciousness.
  • 24. System Effect positive Effect negative CNS • Thiopentone can also be used in Intensive Care patients with head injuries to control surges in intracranial pressure. • it posesses potent anticonvulsant activity it may be given to treat epileptic seizures • CMRO, CBF GIS and US • It does not have any direct toxic effects on the liver or kidney, but patients with liver or kidney disease may require a lower dose range than 3 to 7 mg/kg. /-/ CVS • it increases heart rate, coronary blood flow, and the oxygen demand of the heart. • Thiopentone directly depresses the contractile force of the heart • can cause hypotension in patients who are hypovolaemic (eg following haemorrhage). • also causes a decrease in venous tone, causing pooling of blood in the peripheral veins; Analgesic and muscle relaxant Thiopentone has no analgesic properties, in fact in low doses it tends to heighten sensitivity to pain. It has poor muscle relaxant properties. /-/ Effect of Organ system
  • 25. • 1. Acute intermittent porphyria • 2. Barbiturate allergy • 3. Patients with a low circulating blood volume, such as after haemorrhage, are prone to severe hypotension with thiopentone. • 4. Patients with cardiac disease (particularly those with stenotic heart valve lesions) are at risk from the cardiovascular depressant effects of thiopentone. The drug must be carefully titrated against effect. • 5. Patients with partial airway obstruction should not be given an intravenous anaesthetic agent in case total airway obstruction develops. • 6. In severe asthma it is thought that thiopentone may occasionally cause bronchospasm. Contraindications:
  • 26. Thiopentone is metabolised in the liver; less than 1% of the drug appears in the urine unchanged.
  • 27. • Midazolam is a water soluble benzodiazepine. It comes as a clear solution.  1mg/ml  5mg/ml • Actions: unconsiousness, sedation , anxiolytic, anticonvulant , amnesia Benzodiazepines(Midazolam)
  • 28. Acting Sedation dose 0.05-0.1mg.kg(IV). Short duration Oral dose (children) 0.5mg.kg Premedication 30min preoperative Induction dose 0.3mg.kg(0.2-0.4mg.kg IV) Onset time 30-90sec Duration time 10-30min Pain injection /-/ It undergoes hepatic metabolism (+glucorinide or oxidation)and renal elimination. In the elderly, the lower hepatic blood flow and metabolic activity result in a significantly prolonged half life. Liver clearance rate : midazolam >lorazepam >diazepam
  • 29. System Effect positive Effect negative CvS /-/ Mild depressant* RS /-/ Mild depressant * CNS Anticonvulsant ,antiepileptic CMRO2 and CBF *-dose dependant (monitoring is important duration sedation) When used as a sole induction drug, midazolam causes apnoea in up to 70% of patients The effects of midazolam can be reversed with flumazenil, a competitive benzodiazepine antagonist. This should be given by intravenous injection in 100mcg increments and should act with in 2 minutes. Flumazenil must be used cautiously, as it can cause agitation and seizures Effect of Organ system
  • 30. • Diazepam is exclusively lipid soluble, water insoluble due to its carbon-containing ring structure. • This property makes it a rapidly absorbed by the oral route but also means that it must be formulated as a lipid emulsion (diazemuls) for intravenous use  5mg/1ml Diazepam
  • 31. Diazepam Induction dose 0.3-0.6mg.kg Dose in children 0.2-0.3mg.kg Onset time 45-60sec Duration time 15-30min Pain on injectin +++ Diazepam causes cardiorespiratory compromise, particularly when co-administered with opioids.
  • 32.
  • 33. • Etomidate is an imidazole ester. • It is usually presented as a lipid emulsion or as a clear solution containing propylene glycol at a concentration of 2mg.ml  2mg/ml Etomidate
  • 34. Induction dose 0.2-0.3 mg.kg Sedation dose 0.03-0.05mg.kg Onset time 15-45sec Duration time 3-12min Pain on injectin +++ Recovery rapid (accompanied by nausea and vomiting) It is rapidly metabolized by hepatic and plasma esterases to yield inactive metabolites. Excretion is predominantly urinary and the elimination half life varies from 1 – 5 hours.
  • 35. System Effect positive Effect negative CVS • widely used to induce anaesthesia in the shocked, elderly or cardiovascularly compromised patient • Hemodynamic suitable • Least cardiovascular depression of the IV anaesthetic drugs, with only a small reduction in the cardiac output and blood pressure. • Deppressant trombocytes , prolonged bleeding time RS /-/ • causes transient apnoea, though less so than other drugs, and can cause cough or hiccups Post operative nausea and vomiting is common after etomidate administration MOST MINIMUM DEPRESSANT !!!!! Effect of Organ system
  • 36. • Etomidate inhibits 11-β-hydroxylase, an enzyme important in adrenal steroid production. • A single induction dose blocks the normal stress-induced increase in adrenal cortisol production for 4-8 hours, and up to 24 hours in elderly and debilitated patients. • Continuous infusion of etomidate for sedation in critically ill patients has been shown to increase mortality. • Although no increase in mortality has been identified following a single dose during induction of anesthesia, the use of etomidate has declined in recent years due to a perceived potential morbidity Etomidate
  • 37. Weblinks: 1. file:///H:/%C2%A0/Books%20of%20Anesthesiology/Pharmacology%20and%20Ph ysiology%20for%20Anaesthesia.pdf 2. file:///H:/%C2%A0/Books%20of%20Anesthesiology/Barash's%20Handbook%20of %20Clinical%20Anesthesia%207th%20Edition.pdf 3. http://www.e-safe- anaesthesia.org/e_library/03/Ketamine_in_anaesthetic_practice_TOTW_027_2006. pdf 4. http://www.e-safe- anaesthesia.org/e_library/03/Induction_drugs_used_in_anaesthesia_Update_2008.p df 5. http://www.e-safe-anaesthesia.org/e_library/03/Thiopentone_Update_1993.pdf 6. https://www.minervamedica.it/en/getfreepdf/7Bgc25XMfY%252FxrQmpROZRCio IEuJjmBgj1OVQvpXO4zG%252B5tbWLZvXw0Ot70ybHmn6VRMbuu9yOvnNu %252FBxEqzYBg%253D%253D/R02Y2009N05A0339.pdf